Cite Filings / REGN / 0001104659-23-016829
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

REGENERON PHARMACEUTICALS, INC. · Filed 2023-02-09 · Acc 0001104659-23-016829

Documents 1

  • SC 13G/A Amended Statement of Ownership , tv01773-regeneronpharmaceuti.htm

Around this filing

  • 2023-02-13 SC 13G/A Amended Statement of Ownership
  • 2023-02-09 SC 13G/A Amended Statement of Ownership
  • 2023-02-09 SC 13G/A Amended Statement of Ownership
  • 2023-02-08 4 Director sold 3,613 shares at $800.00 ($2,890,400)
  • 2023-02-08 4 Director sold 3,571 shares at an average $797.86 ($2,849,158)
  • 2023-02-08 4 President and Chief Scientific sold 13,189 shares at $800.08 ($10,552,255)
  • 2023-02-08 4 EVP Commercial sold 1,000 shares at $769.04 ($769,040)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tv01773-regeneronpharmaceuti.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…